| Q38208944 | A killer choice for cancer immunotherapy |
| Q35543911 | Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells |
| Q39626025 | Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells |
| Q36611629 | An engineered three-dimensional gastric tumor culture model for evaluating the antitumor activity of immune cells in vitro |
| Q39679850 | Antitumor activity of water extracts from Cordyceps militaris in NCI-H460 cell xenografted nude mice |
| Q38223594 | Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer |
| Q37205970 | Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib |
| Q38687547 | Cancer Immunotherapy with Cytokine-Induced Killer Cells. |
| Q34111201 | Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). |
| Q37886333 | Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one? |
| Q36153869 | Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report |
| Q38088013 | Current Adoptive Immunotherapy in Non-Small Cell Lung Cancer and Potential Influence of Therapy Outcome |
| Q38002494 | Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. |
| Q94450780 | Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer |
| Q58759294 | Cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis |
| Q38574526 | Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives |
| Q36741617 | Cytokine-induced killer cells promote antitumor immunity |
| Q42174988 | Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models |
| Q34127138 | Experimental approaches for the treatment of malignant gliomas |
| Q34382415 | Growth of Human Colorectal Cancer SW1116 Cells Is Inhibited by Cytokine-Induced Killer Cells |
| Q61445430 | Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15 |
| Q39179098 | Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients |
| Q36592772 | Inhibition of human pancreatic tumor growth by cytokine-induced killer cells in nude mouse xenograft model |
| Q37996561 | New adoptive immunotherapy strategies for solid tumours with CIK cells |
| Q33415850 | Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer |
| Q55504567 | Researche advances on CIK cells and their clinical use in lung cancer |
| Q52764149 | Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model |
| Q41968968 | T-Bet Mediated Anti-Neoplastic Effects of Dendritic Cell-Cytokine Induced Killer Cells in vitro |
| Q45354258 | The CIK cells stimulated with combination of IL-2 and IL-15 provide an improved cytotoxic capacity against human lung adenocarcinoma |
Search more.